These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2748995)

  • 1. Effects of N1,N3-diallyluracil and N1,N3-diallylthymine on hepatic drug-metabolizing enzymes of mice.
    Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):135-43. PubMed ID: 2748995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of N,N'-diallylpentobarbital potentiation of pentobarbital-induced sleep in mice.
    Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):173-85. PubMed ID: 3659568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiating effects of N1,N3-diallyluracil, N1,N3-diallylthymine and N1,N3-diallyl-6-methyluracil on pentobarbital-induced sleep and diazepam-induced motor incoordination.
    Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
    Chem Pharm Bull (Tokyo); 1987 Dec; 35(12):4928-34. PubMed ID: 3451813
    [No Abstract]   [Full Text] [Related]  

  • 4. Central depressant activities of N3-allyluridine and N3-allylthymidine.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):321-32. PubMed ID: 3738212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatic drug-metabolizing enzymes by arachidonic acid.
    Pessayre D; Mazel P; Descatoire V; Rogier E; Feldmann G; Benhamou JP
    Xenobiotica; 1979 May; 9(5):301-10. PubMed ID: 115160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based inactivation of mouse hepatic cytochrome P4502B enzymes by amine metabolites of musk xylene.
    Lehman-McKeeman LD; Johnson DR; Caudill D; Stuard SB
    Drug Metab Dispos; 1997 Mar; 25(3):384-9. PubMed ID: 9172959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potentiation of barbiturate-induced narcosis by procarbazine.
    Lee IP; Lucier GW
    J Pharmacol Exp Ther; 1976 Mar; 196(3):586-93. PubMed ID: 1263114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
    Hietanen E; Ahotupa M; Heikelä A; Laitinen M
    Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prolonging effect of N,N'-diallylpentobarbital on the drug-induced sleep and motor incoordination.
    Yamamoto I; Tateoka Y; Watanabe K; Nabeshima T; Fontenot HJ; Ho IK
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):209-19. PubMed ID: 4081315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypnotic activities of N3-benzyl and xylyl substituted arabinofuranosyluracil.
    Kimura T; Chun YS; Ikeda M; Kobana K; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1997; (37):229-30. PubMed ID: 9586083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
    Kaul KL; Novak RF
    J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro metabolic studies of N3-benzyluridine which exhibits hypnotic activity in mice.
    Kimura T; Yamamoto I; Watanabe K; Tateoka Y; Ho IK
    Res Commun Chem Pathol Pharmacol; 1991 Jan; 71(1):27-48. PubMed ID: 2024063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interactions between theophylline and drug metabolizing liver enzymes in the rat].
    Lissner R; Merk H; Bolsen K; Goerz G
    Arzneimittelforschung; 1985; 35(12):1825-7. PubMed ID: 4096737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of the barbiturate sleeping time in mice as predictive tool for the detection of liver enzymes inhibiting drugs.
    André P; Descotes J; Simonet R; Evreux JC
    Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):695-9. PubMed ID: 6530908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of desoxycorticosterone on the activity of drug-metabolizing enzyme systems.
    Tantcheva L; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1989; 15(2):33-9. PubMed ID: 2801146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of Carmustine (BCNU) treated mice to induction and inhibition of mixed function oxygenases.
    Wilson VL; Larson RE
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):439-48. PubMed ID: 7122989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.